Methylation tests

The HUS Group requested tenders for MGMT and MLH1 methylation tests. The procurement includes the following products: - MGMT and MLH1 methylation tests. The procurement is divided into two (2) product groups, which are: Product group 1: MGMT methylation tests Product group 2: MLH1 promotor methylation tests The supplier could bid on one or both sections of the procurement. The estimated number of MGMT methylation tests per year is around 200. The estimated number of MLH1 promotor methylation tests per year would be around 80. The products were described in more detail in invitation to tender and in Appendix 2 to the invitation to tender (Price and product form). In each subarea the most economically advantageous tender shall be selected. The criterion for determining the most economically advantageous tender shall be the best price-quality ratio. Price is weighted at 80 % and quality is weighted at 20 %. The comparison criteria for subareas 1-2, how to perform the comparison, and the related calculation formulas are described in more detail in the "General criteria of the sub-area" section of each subarea. HUS will select for each area two (2) contract suppliers in the ranking order of the tenderers. More information about the order of priority and its formation can be found in the section "Grounds for decision". The goal of this competitive procurement was to get products that are safe to use. The goal was also to have good product delivery reliability and to have products available when they are needed. During the contract period, products belonging to the product groups that are the subject of the contract, may be acquired in accordance with the estimated value of the contract, also when they are not specified in the Appendix 2 Product and price form (please see Agreement). The Agreement is in force for a fixed period of 3 years, and thereafter until terminated. The aim is to bring the agreement into force as soon as possible after the procurement procedure has been completed. The estimated starting day for the contract period is 3.11.2025 The products requested in this invitation to tender will be used by the Genetics Laboratory of the HUS Diagnostic Centre (Helsinki University Hospital, HUS Group). See Annex 1 (Agreement) of the call for tenders for details. The total estimated value of the procurement (VAT 0%) is approximately EUR 620 000 for 48 months. This is an estimate and the contracting entity does not commit neither to the stated euro amounts and nor the consumption figures indicated in the invitation to tender. The final order quantities may be higher or lower than stated. The subject matter and requirements of the procurement are described in detail in the invitation to tender and its annexes.Main features of the procedureThe procurement shall comply with the Act on Public Procurement and Concession Contracts (1397/2016, referred to as the Public Procurement Act). The procurement value exceeds the EU threshold value. The procedure shall be an open procedure as defined in section 32 of the Public Procurement Act. PROCESSING OF TENDERS The procedure shall include the following phases: Contracting entity 1. Opens the tenders 2. Verifies the suitability of the tenderer 3. Checks that the tenders conform to the invitation to tender 4. Compares the tenders [POSSIBLE TRIAL USE] 5. Requests and checks certificates and reports on the suitability of the winning tenderer(s) 6. Makes a procurement decision and communicates it to all the tenderers 7. Concludes an agreement with the selected tenderer(s) LANGUAGE OF THE COMPETITIVE TENDERING PROCEDURE The procurement documents are available in English. If a tenderer needs the documents in another language, the tenderer shall be responsible for translation and liable for the associated costs. Tenders must be prepared in English. PARALLEL TENDERS Parallel tenders are not permitted.